Literature DB >> 24649310

A retrospective clinicopathological analysis of small-cell carcinoma of the uterine cervix.

Samina Dongol1, Yanhong Tai2, Yi Shao3, Jie Jiang1, Beihua Kong1.   

Abstract

Cervical cancer encompasses several histological types, including neuroendocrine tumors (NETs). Small-cell carcinoma of the uterine cervix (SCCC) is the most common and aggressive subtype of cervical NET. The objective of this case report was to investigate SCCC using a retrospective clinicopathological approach. Four cases of large (≥4 cm) SCCCs are presented in this case study. The patients were diagnosed with SCCC through a sequential hierarchy of physical examinations, laboratory reports, radiological reports, immunohistochemical and pathological tests. The diagnosis for each case was made at various stages (Ib1, Ib2, IIa2 and IIb, according to the FIGO staging system, 2000) and each of the patients received different multimodality therapeutic regimens. All the patients underwent radical hysterectomy and pelvic lymphadenectomy, followed by adjuvant chemotherapy. Neoadjuvant chemotherapy was administered prior to surgery in two of the patients. The clinical and pathological analyses were assessed using a retrospective measure, maintaining timely follow-ups. SCCC is a rare but serious gynecological malignancy. This condition has a poor prognosis due to its high aggressiveness, high rate of metastases and mortality. Furthermore, the rarity of this disease represents a hindrance to adequate research and development of novel, efficient therapeutic regimens.

Entities:  

Keywords:  multimodal treatment regimen; neoadjuvant chemotherapy; prognostic factor; small-cell carcinoma of cervix

Year:  2013        PMID: 24649310      PMCID: PMC3915860          DOI: 10.3892/mco.2013.193

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  26 in total

1.  Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix.

Authors:  D M Boruta; J O Schorge; L A Duska; C P Crum; D H Castrillon; E E Sheets
Journal:  Gynecol Oncol       Date:  2001-04       Impact factor: 5.482

Review 2.  [Clinicopathological analysis of nine cases of small cell carcinoma of the uterine cervix].

Authors:  Guo-hua Deng; Xun Zhang; Ling-ying Wu
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2010-03

3.  Large cell neuroendocrine [corrected] carcinoma of the uterine cervix: a clinicopathologic study of 12 cases.

Authors:  C B Gilks; R H Young; D J Gersell; P B Clement
Journal:  Am J Surg Pathol       Date:  1997-08       Impact factor: 6.394

4.  Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma.

Authors:  E E Sheets; M L Berman; C K Hrountas; S Y Liao; P J DiSaia
Journal:  Obstet Gynecol       Date:  1988-01       Impact factor: 7.661

5.  Small cell carcinoma of the cervix in liquid-based Pap test: utilization of split-sample immunocytochemical and molecular analysis.

Authors:  T Giorgadze; R Kanhere; C Pang; C Ganote; L E Miller; P Tabaczka; E Brown; M Husain
Journal:  Diagn Cytopathol       Date:  2010-10-01       Impact factor: 1.582

6.  Presentation of a patient with pT2bN1M0 small cell carcinoma of the uterine cervix who obtained long-term survival with maintenance chemotherapy, and literature-based discussion.

Authors:  M Futagami; Y Yokoyama; H Mizunuma
Journal:  Eur J Gynaecol Oncol       Date:  2011       Impact factor: 0.196

7.  Neuroendocrine carcinoma of the cervix: implications for staging and therapy.

Authors:  R Pazdur; P Bonomi; R Slayton; V E Gould; A Miller; W Jao; T Dolan; G Wilbanks
Journal:  Gynecol Oncol       Date:  1981-08       Impact factor: 5.482

8.  Large cell neuroendocrine carcinoma of the cervix: prognostic factors and survival advantage with platinum chemotherapy.

Authors:  Julia R Embry; Michael G Kelly; Miriam D Post; Monique A Spillman
Journal:  Gynecol Oncol       Date:  2010-12-07       Impact factor: 5.482

9.  Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy.

Authors:  P J Hoskins; K D Swenerton; J A Pike; P Lim; C Aquino-Parsons; F Wong; N Lee
Journal:  J Clin Oncol       Date:  2003-09-15       Impact factor: 44.544

10.  Neuroendocrine features in poorly differentiated and undifferentiated carcinomas of the cervix.

Authors:  R J Barrett; I Davos; R S Leuchter; L D Lagasse
Journal:  Cancer       Date:  1987-11-01       Impact factor: 6.860

View more
  9 in total

1.  Overexpression of Karyopherin α2 in small cell carcinoma of the cervix correlates with poor prognosis.

Authors:  Ling-Min Liao; Zhen-Bang Gu; Ming Fang; Gong-Ji Yao; Long Huang
Journal:  Int J Clin Exp Pathol       Date:  2022-06-15

2.  MR imaging features and staging of neuroendocrine carcinomas of the uterine cervix with pathological correlations.

Authors:  Xiaohui Duan; Xiaohua Ban; Xiang Zhang; Huijun Hu; Guozhao Li; Dongye Wang; Charles Qian Wang; Fang Zhang; Jun Shen
Journal:  Eur Radiol       Date:  2016-03-19       Impact factor: 5.315

3.  Clinicopathological features of small cell carcinoma of the uterine cervix in the surveillance, epidemiology, and end results database.

Authors:  Juan Zhou; San-Gang Wu; Jia-Yuan Sun; Li-Ying Tang; Huan-Xin Lin; Feng-Yan Li; Qiong-Hua Chen; Xin Jin; Zhen-Yu He
Journal:  Oncotarget       Date:  2017-06-20

4.  Association of P73 polymorphisms with susceptibilities of cervical carcinoma: a meta-analysis.

Authors:  Xianghua Liang; Bingxiang Chen; Jianxin Zhong
Journal:  Oncotarget       Date:  2017-05-24

5.  Prognostic Factors and Local Treatment Modalities of Small-Cell Carcinoma of the Cervix: An Analysis According to the International Federation of Gynecology and Obstetrics Stage.

Authors:  Ru Huang; Qiyu Gan; Jingxin Cheng
Journal:  Cancer Manag Res       Date:  2020-05-14       Impact factor: 3.989

6.  Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix.

Authors:  Shi-Wen Zhang; Rong-Zhen Luo; Xiao-Ying Sun; Xia Yang; Hai-Xia Yang; Si-Ping Xiong; Li-Li Liu
Journal:  BMC Cancer       Date:  2021-03-31       Impact factor: 4.430

Review 7.  Small Cell (Neuroendocrine) Carcinoma of the Cervix: An Analysis for 19 Cases and Literature Review.

Authors:  JunLing Lu; Ya Li; Jun Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-07-13       Impact factor: 6.073

8.  Neuroendocrine carcinoma of the cervix: a systematic review of the literature.

Authors:  Clemens B Tempfer; Iris Tischoff; Askin Dogan; Ziad Hilal; Beate Schultheis; Peter Kern; Günther A Rezniczek
Journal:  BMC Cancer       Date:  2018-05-04       Impact factor: 4.430

9.  Prognostic factors and treatment of neuroendocrine tumors of the uterine cervix based on the FIGO 2018 staging system: a single-institution study of 172 patients.

Authors:  Jian Chen; Yang Sun; Li Chen; Lele Zang; Cuibo Lin; Yongwei Lu; Liang Lin; An Lin; Hu Dan; Yiyu Chen; Haixin He
Journal:  PeerJ       Date:  2021-07-06       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.